Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METILDIGOXIN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 10 adverse event reports in the FDA FAERS database where METILDIGOXIN was used for Atrial fibrillation.

Most Reported Side Effects for METILDIGOXIN

Side Effect Reports % Deaths Hosp.
Dyspnoea 42 38.9% 0 28
Bradycardia 28 25.9% 0 27
Dizziness 18 16.7% 0 16
Off label use 17 15.7% 1 17
Wound haemorrhage 16 14.8% 0 16
Drug interaction 15 13.9% 0 9
General physical health deterioration 15 13.9% 0 0
Decreased appetite 14 13.0% 1 1
Medication error 14 13.0% 0 14
Pleural effusion 14 13.0% 0 13
Therapeutic product effect decreased 14 13.0% 0 14
Cardiac failure chronic 13 12.0% 0 12
Fatigue 13 12.0% 0 0
Tachycardia 13 12.0% 0 12
Aortic stenosis 12 11.1% 0 12

Other Indications for METILDIGOXIN

Product used for unknown indication (60) Cardiac failure (6) Arrhythmia (5)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

METILDIGOXIN Full Profile All Atrial fibrillation Drugs METILDIGOXIN Demographics METILDIGOXIN Timeline